WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: APRIL ISSUE PUBLISHED
  • April Issue has been successfully launched on 1 April 2024.

Abstract

HUNTINGTON’S DISEASE

*Wakale Megha Shantaram, Kale Akash Laxman, Shete Nikhil Arun, Kate Prashant R., Sawant Mayuri Rajesh and Tambe Mahesh

ABSTRACT

Huntington disease(HD) is a one of the most popular disease in which neurological as well as psychological disorder characterised by the immune, cognitive as well as external behavioural changes of human being. It is rapidly increasing most autosomal dominent disorder is genetically inherited disease are mostly affected by both male and female of huntington disease observed in equally.[1] In these disease severe symptoms are seen above the 40 years age people also. Huntington disease is a widely spread disease in other countries. A rare juvenile Huntington disease has observed in the not only children but also adult people. The dignosis of these disease is insidious not only structural but also functional CNS changes may be present in more than a decade before the signs as well as symptoms become manifestrate.[2] The Huntington disease diagnosis is depend upon the living sign and also symptoms in an individual with person to person and also confirmed by DNA determination. In the Pre-manifestration diagnosis of HD is only performed by multidisciplinary teams in healthy the risk of adult individuals who has been want to know whether they are carried out the gene mutation.[3] overall, the evidance are most commonly based on the pharmacological treatment of Huntington’s Disease is occurs in countries and also poor countries. They have clear need in the future better quality of medicines are commercially used to controlled in clinical trials on the psychological treatment of the Huntington disease. In commercially on the pharmacotherapy of non-motor or disturbance of motar nerve symptoms of Huntington disease.[3] There are no specific treatment are available in immediate recovery of Huntington disease. The education and symptomatic therapies mostly effective tools to used with the patients and also the patient families are commonly affected by Huntington disease.[4] A surge of publications of Huntington disease are mainly found in from 1996 to 1997 in world wide. In relation between the various types of knowledgeable areas that can emerged, most publications were in the fields of neuroscience and neurology, likely because of Huntington disease is a neurological as well as psychological disorder. In publications are mainly written in areas mostly include in psychiatry, genetics, and also molecular biology is also predominated in the Huntington disease.[5]

Keywords: Chorea, Neurological Disorder, gene, Huntington's disease.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More